Lymphomas

Priority Review Granted for Axicabtagene Ciloleucal in NHL

By May 26, 2017

In the ZUMA-1 trial 42% of patients demonstrated ongoing response at the 8.7-month follow-up, of which 39% achieved complete response.

Exercise Important for Men After Cancer Diagnosis

January 28, 2014

Men who are physically active after a cancer diagnosis have significantly improved survival.